Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP570436.RArmfdNab-nLPIE_BEivgQzYqWRePSFzHyJWokCWhW69c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP570436.RArmfdNab-nLPIE_BEivgQzYqWRePSFzHyJWokCWhW69c130_assertion type Assertion NP570436.RArmfdNab-nLPIE_BEivgQzYqWRePSFzHyJWokCWhW69c130_head.
- NP570436.RArmfdNab-nLPIE_BEivgQzYqWRePSFzHyJWokCWhW69c130_assertion description "[Multidrug resistance (MDR), usually mediated by overexpression of efflux transporters such as P-gp, ABCG2 and/or MRP1, remains a major obstacle hindering successful cancer chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP570436.RArmfdNab-nLPIE_BEivgQzYqWRePSFzHyJWokCWhW69c130_provenance.
- NP570436.RArmfdNab-nLPIE_BEivgQzYqWRePSFzHyJWokCWhW69c130_assertion evidence source_evidence_literature NP570436.RArmfdNab-nLPIE_BEivgQzYqWRePSFzHyJWokCWhW69c130_provenance.
- NP570436.RArmfdNab-nLPIE_BEivgQzYqWRePSFzHyJWokCWhW69c130_assertion SIO_000772 24032744 NP570436.RArmfdNab-nLPIE_BEivgQzYqWRePSFzHyJWokCWhW69c130_provenance.
- NP570436.RArmfdNab-nLPIE_BEivgQzYqWRePSFzHyJWokCWhW69c130_assertion wasDerivedFrom befree-20150227 NP570436.RArmfdNab-nLPIE_BEivgQzYqWRePSFzHyJWokCWhW69c130_provenance.
- NP570436.RArmfdNab-nLPIE_BEivgQzYqWRePSFzHyJWokCWhW69c130_assertion wasGeneratedBy ECO_0000203 NP570436.RArmfdNab-nLPIE_BEivgQzYqWRePSFzHyJWokCWhW69c130_provenance.